Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927951 · ClinicalTrials.gov registry record · Phase 3
The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy
A Phase 3 study of Diabetic Peripheral Neuropathy and Nerve Pain, sponsored by Eastern Virginia Medical School.
- Completed
- Registry status
- Phase 3
- Development phase
- 44
- Enrollment target
- 2
- Study locations
NCT02927951 is a Phase 3 study of Diabetic Peripheral Neuropathy and Nerve Pain that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 44 participants, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02927951, a Phase 3 study of Diabetic Peripheral Neuropathy and Nerve Pain, has completed, sponsored by Eastern Virginia Medical School.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 44 participants
- Enrollment target
- 2
- Study locations
Study Summary
The hypothesis of this study is that pregabalin, 150 mg bid, will reduce general daytime pain in patients diagnosed with diabetic peripheral neuropathy and that it will also reduce the level of pain associated with walking. Consequently, it is hypothesized that the reduction in pain will result in an increase in the amount of walking they do during the day, improvements in their gait, balance, risk of falls and sleep patterns.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pregabalin
Study Locations (2)
Virginia
- Eastern Virgnia Medical School, Strelitz Diabetes Center - Norfolk
- Strelitz Diabetes Center - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02927951
The ClinicalTrials.gov registry entry for NCT02927951 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 17 other Diabetic Peripheral Neuropathy trials with a reported enrollment target (65% lower). The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Peripheral Neuropathy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02927951 reports 2 study locations spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT02927951 about?
NCT02927951 is a clinical study titled "The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy". The hypothesis of this study is that pregabalin, 150 mg bid, will reduce general daytime pain in patients diagnosed with diabetic peripheral neuropathy and that it will also reduce the level of pain associated with walking. Consequently, it is hypothesized that the reduction in pain will result in a...
What is the current status of trial NCT02927951?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2011-01. Estimated completion is 2013-12.
What conditions does trial NCT02927951 study?
This clinical trial studies the following conditions: Diabetic Peripheral Neuropathy, Nerve Pain.
What interventions are being tested in trial NCT02927951?
The interventions under investigation include: Placebo (DRUG), Pregabalin (DRUG).
Who is sponsoring clinical trial NCT02927951?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02927951 being conducted?
This trial has 2 study locations across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy
COMPLETED · Phase 3
-
Walking Function in Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Spinal Cord Stimulation and Small Fiber Peripheral Neuropathy
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Functional and Neuroprotective Effects of Restoring Lower Limb Sensation After Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Balance Control and Recovery in Diabetes Peripheral Neuropathy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.